Hildenbrand R, Jansen C, Wolf G, Böhme B, Berger S, von Minckwitz G, Hörlin A, Kaufmann M, Stutte H J
Department of Pathology, University Frankfurt am Main, Germany.
Lab Invest. 1998 Jan;78(1):59-71.
Recent studies have shown that urokinase (uPA) is an independent prognostic marker in breast cancer. uPA plays a key role in the degradation of tumor matrix and promotes tumor progression. Macrophage expression of uPA appears to be important in this context. Our objective in the present study was to provide evidence that tumor growth factor-beta (TGF-beta) released from breast cancer cells markedly up-regulates uPA expression in tumor-associated macrophages (TAMs). TAMs from 32 breast carcinomas were cultured. Blood monocytes from healthy donors and breast cancer patients as well as tissue macrophages from patients with fibrocystic changes of the breast were also examined. After TGF-beta incubation, uPA levels were tested by ELISA, and uPA mRNA levels were determined by Northern blot analysis. TGF-beta receptor and uPA cell surface fluorescence intensities were determined by flow cytometry; TGF-beta receptors were determined by Western blot analysis. Protein kinase-C dependence was also examined, and immunohistochemical stainings for uPA and TGF-beta were performed. We have demonstrated that TGF-beta markedly up-regulates basal uPA expression (mRNA and protein) in TAMs but only modestly increases uPA production in blood monocytes and tissue macrophages. Exposure of macrophages to TGF-beta1 led to a rapid and sustained increase in uPA mRNA levels, which was independent of de novo protein synthesis and completely inhibited by actinomycin D. H7 markedly reduced the ability of TGF-beta to stimulate uPA expression. Likewise, okadaic acid potentiated the ability of TGF-beta to up-regulate macrophage uPA expression. We suggest that TAMs are more responsive to TGF-beta stimulation than are blood monocytes and tissue macrophages because of different TGF-beta receptor densities. TGF-beta stimulates transcription of the uPA gene, increases uPA-mRNA stability, and activates uPA expression via protein kinase-C-dependent mechanisms. The ability of TGF-beta to induce macrophage uPA expression may provide an indirect mechanism by which this growth factor stimulates angiogenesis. It may be, therefore, that TAMs promote tumor progression and tumor angiogenesis.
最近的研究表明,尿激酶(uPA)是乳腺癌的一个独立预后标志物。uPA在肿瘤基质降解中起关键作用,并促进肿瘤进展。在这种情况下,巨噬细胞中uPA的表达似乎很重要。我们在本研究中的目的是提供证据表明,乳腺癌细胞释放的肿瘤生长因子-β(TGF-β)显著上调肿瘤相关巨噬细胞(TAM)中的uPA表达。培养了32例乳腺癌的TAM。还检测了健康供体和乳腺癌患者的血液单核细胞以及乳腺纤维囊性变患者的组织巨噬细胞。TGF-β孵育后,通过ELISA检测uPA水平,通过Northern印迹分析测定uPA mRNA水平。通过流式细胞术测定TGF-β受体和uPA细胞表面荧光强度;通过Western印迹分析测定TGF-β受体。还检测了蛋白激酶-C依赖性,并进行了uPA和TGF-β的免疫组织化学染色。我们已经证明,TGF-β显著上调TAM中基础uPA表达(mRNA和蛋白质),但仅适度增加血液单核细胞和组织巨噬细胞中的uPA产生。巨噬细胞暴露于TGF-β1导致uPA mRNA水平迅速且持续增加,这与从头蛋白质合成无关,并被放线菌素D完全抑制。H7显著降低了TGF-β刺激uPA表达的能力。同样,冈田酸增强了TGF-β上调巨噬细胞uPA表达的能力。我们认为,由于不同的TGF-β受体密度,TAM比血液单核细胞和组织巨噬细胞对TGF-β刺激更敏感。TGF-β刺激uPA基因的转录,增加uPA-mRNA稳定性,并通过蛋白激酶-C依赖性机制激活uPA表达。TGF-β诱导巨噬细胞uPA表达的能力可能提供了一种间接机制,通过该机制这种生长因子刺激血管生成。因此,TAM可能促进肿瘤进展和肿瘤血管生成。